Citadel Advisors - IMMUNOCELLULAR THERAPEUTICS ownership

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 20 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q3 2018$15,000
-57.1%
69,746
-48.7%
0.00%
Q2 2018$35,000
-64.6%
136,043
-65.5%
0.00%
Q1 2018$99,000394,6550.00%
Other shareholders
IMMUNOCELLULAR THERAPEUTICS shareholders Q2 2018
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 276,530$5,0000.00%
IFP Advisors, Inc 95$00.00%
Certified Advisory Corp 20$00.00%
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders